From investor Phil Nadel. “Why am I telling you this? Because I am concerned. Concerned about the current startup investing environment, concerned about the lack of due diligence, concerned about the impact of FOMO (fear of missing out) overcoming investors’ […]
Little FDA enforcement and bold claims make for a problematic pair. “Although stem cells for some conditions promoted by the clinics Turner studied have produced promising results in early-phase studies, they generally haven’t been shown to be safe and effective […]
“Brain stimulation is booming… This expanding field of research is slowly revealing truths of the brain: how it works, how it malfunctions, and how electrical impulses, precisely targeted and controlled, might be used to treat psychiatric and neurological disorders.” | learn more
“Working out at different times of the day might have unique benefits for health, an ambitious new study in mice suggests.” | learn more
“Chemistry is a harmonious or effective interaction between people working together. Just as any other great relationship, a mentorship needs chemistry to reach its full potential. If it’s not already there, how can you set the stage to build chemistry […]
Jason Fried of Basecamp writes about their evolution from caring about teammates away status (presence) to not. “But it wasn’t until we gave up on Presence that we really got to embrace the sense of calm that comes from not […]
From famed investor Howard Marks: “The more I’ve thought about it since writing Liquidity, the more convinced I’ve become that there are two main reasons why people sell investments: because they’re up and because they’re down.” | learn more
“Start-ups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain.” This article in Scientific American profiles the billionaire-backed Calico Life Sciences, Life Biosciences, and Turn Biotechnologies. | learn more
“If innovative reactor designs can’t pass muster with the federal government, the U.S. nuclear industry is in trouble.” | learn more
“I went through my inbox and every single stock chart that was being marketed through the IPO Access program looked like that [a downward sloping line].” | learn more